BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38505782)

  • 1. Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Malik A; Malik M; Qureshi S
    Can Liver J; 2024 Feb; 7(1):40-53. PubMed ID: 38505782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis.
    Malik A; Nadeem M; Malik MI
    Clin J Gastroenterol; 2021 Dec; 14(6):1579-1586. PubMed ID: 34370218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis.
    Malik A; Nadeem M; Amjad W; Malik MI; Javaid S; Farooq U; Naseem K; Khan A
    Prz Gastroenterol; 2023; 18(1):67-75. PubMed ID: 37007760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis.
    Li S; Duan F; Li S; Lu B
    Ann Hepatol; 2024; 29(2):101174. PubMed ID: 38579127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
    Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
    J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.
    de Avelar CR; Pereira EM; de Farias Costa PR; de Jesus RP; de Oliveira LPM
    World J Gastroenterol; 2017 Jul; 23(27):5004-5017. PubMed ID: 28785154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic fatty liver: a systematic review and meta-analysis.
    Wang T; Song J; Hu J; Feng S; Zhang H; Wang H; Li B
    Ann Palliat Med; 2021 Dec; 10(12):12969-12984. PubMed ID: 33691456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
    Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta-analysis of randomized controlled trials.
    Ardekani A; Tabrizi R; Maleki E; Bagheri Lankarani K; Heydari ST; Moradinazar M; Akbari M
    Food Sci Nutr; 2023 Jun; 11(6):2580-2588. PubMed ID: 37324909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials.
    Malik A; Amjad W; Inayat F; Nadeem M; Weissman S; Malik MI; Jajja AA; Khan A; Tabibian JH
    Prz Gastroenterol; 2023; 18(1):100-109. PubMed ID: 37007754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.